Our digital diagnostics tools are creating a safer world, one infectious disease test at a time.
Application
Infectious Disease


Challenges & Solution
As lab technicians battle eye strain, physical fatigue, and piled-on workloads, their efforts are more prone to human error.
Techcyte saves laboratories time and money by providing hematopathologists access to AI-driven computer-assisted blood differentials.

Partnership
NanoSpot.AI
We partnered with ARUP Laboratories and the University of Utah to develop NanoSpot.AI, an ultra-fast, high-quality test that measures COVID-19 antibodies.
The test is significantly less expensive to manufacture than other SARS-CoV-2 antibody tests due to its performance on a spot of blood obtained through a finger prick.
The entire user process is conducted through the individual’s mobile phone, from image capture to test results.
Diagnostics on the Spot
-
Article
Partnership announced to develop ultra-fast test for COVID-19 antibodies -
Case study
A rapid and affordable point-of-care test for detection of SARS-CoV-2-specific antibodies based on hemagglutination and Artificial Intelligence-based image interpretation -
Article
University of Utah, ARUP and Techcyte develop Nanospot.ai, a new ultra-fast test for COVID-19 antibodies -
Article
University of Utah, ARUP, and Techcyte Develop NanoSpot.AI, a New Ultra-Fast Test for COVID-19 Antibodies -
PRESS RELEASE
Rapid antibody test created in Utah, could be available as soon as summer -
ARTICLE
Artificial Intelligence Powers Rapid COVID-19 Antibody Test